MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-06-30, TRML had $917K increase in cash & cash equivalents over the period. -$41,959K in free cash flow.

Cash Flow Overview

Change in Cash
$917K
Free Cash flow
-$41,959K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Maturities of investments
    • Stock-based compensation expense
    • Accrued expenses and other curre...
    • Others
Negative Cash Flow Breakdown
    • Purchases of investments
    • Accretion of discount on investm...
    • Accounts payable
    • Others

Cash Flow
2025-06-30
Net loss
-46,062
Stock-based compensation expense
4,739
Realized gain on investments
0
Non-cash lease expense
86
Prepaid expenses and other current assets
-670
Other non-current assets
-618
Operating lease liabilities
-99
Accrued expenses and other current liabilities
1,687
Accounts payable
-609
Depreciation on property and equipment
24
Accretion of discount on investments
2,997
Net cash used in operating activities
-41,943
Maturities of investments
167,878
Purchases of property and equipment
16
Purchases of investments
125,618
Net cash provided by (used in) investing activities
42,244
Proceeds from exercise of stock options
623
Proceeds from public offering of common stock, net of issuance costs
0
Repurchase of common stock originally issued upon early exercise of stock options
7
Net cash provided by financing activities
616
Net increase (decrease) in cash, cash equivalents and restricted cash
917
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Maturities of investments$167,878K Proceeds from exercise ofstock options$623K Net cash provided by(used in) investing...$42,244K Net cash provided byfinancing activities$616K Canceled cashflow$125,634K Canceled cashflow$7K Net increase(decrease) in cash, cash...$917K Canceled cashflow$41,943K Purchases of investments$125,618K Purchases of property andequipment$16K Stock-based compensationexpense$4,739K Accrued expenses andother current...$1,687K Prepaid expenses andother current assets-$670K Other non-currentassets-$618K Non-cash lease expense$86K Depreciation on property andequipment$24K Repurchase of common stockoriginally issued upon...$7K Net cash used inoperating activities-$41,943K Canceled cashflow$7,824K Net loss-$46,062K Accretion of discount oninvestments$2,997K Accounts payable-$609K Operating leaseliabilities-$99K

Tourmaline Bio, Inc. (TRML)

Tourmaline Bio, Inc. (TRML)